Colombia faces treaty dispute over cancer drug
Swiss pharmaceuticals group Novartis has threatened Colombia with an investment treaty claim over plans to impose price controls on a patented treatment for leukaemia, it has emerged.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.